News
WebMD's Chief Medical Officer, John Whyte, MD, speaks with Eric Topol, MD, Executive Vice President, Scripps Research, and Editor-in-Chief, Medscape, about our current understanding of Long COVID ...
Dr. Eric Topol, Scripps Research Translational Institute: Right, William. Well, there's a significant rate of infections, perhaps around a million people infected, Americans, per day.
Renowned cardiologist Eric Topol, speaks with WebMD Chief Medical Officer John Whyte to discuss what people at home don’t yet know about COVID-19, how certain medications and pre-existing ...
Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid. ... we’ve done very little,” said Eric Topol, ...
COVID XEC variant has been confirmed in 27 countries ... the XEC variant appears to be the most likely one to get legs next," Scripps Research Translational Institute Director Eric Topol wrote on X.
A new COVID variant is raising questions and capturing the attention of researchers heading into the fall and winter season. ... — Eric Topol (@EricTopol) September 15, 2024.
Without widespread acceptance of vaccines, Topol added, there will be no way to end the COVID-19 pandemic, which has already killed nearly 182,000 Americans and sickened nearly 6 million more.
Hosted on MSN10mon
The new COVID vaccine is here. Why these are the best times to ... - MSNDr. Eric Topol, director of the ... Already, it appears that XEC, the new subvariant detected in Europe, may be a contender for a late autumn and winter COVID wave, Topol said.
In California as of July 31, 37% of seniors had received the updated COVID-19 vaccine for the 2023–24 season, as did 18.7% of those age 50 to 64, and 10.1% of the youngest adults. More to Read ...
Join Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, as they interview experts on the hottest topics in healthcare ranging from COVID-19 to ...
The latest strain of COVID originated in June in Germany, but has already spread across Europe, Asia and North America. Here's what to know. ... Eric Topol, on X. Here's what to know.
Long covid patients are desperate for treatments. These trials may help. Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results